Related Experiment Video
Updated: May 24, 2026
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
The extended cleavage specificity of human thrombin
Maike Gallwitz1, Mattias Enoksson, Michael Thorpe
1Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Plos One
|March 3, 2012
Summary
Researchers detailed thrombin
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Thrombin is a key protease in coagulation.
- Its detailed consensus cleavage site remains undetermined.
- Understanding thrombin specificity is crucial for coagulation research.
Purpose of the Study:
- To determine the extended substrate recognition profile of thrombin.
- To investigate the kinetic role of specific residues in thrombin cleavage.
- To elucidate the determinants of thrombin substrate specificity.
Main Methods:
- Phage-display technology was employed to identify substrate sequences.
- A novel system for kinetic analysis of cleavage rates was developed.
- Site-directed mutagenesis was used to assess the impact of key residues.
Main Results:
- The consensus recognition sequence was identified as P2-Pro, P1-Arg, P1'-Ser/Ala/Gly/Thr, P2'-not acidic, P3'-Arg.
- P2-Pro and P3'-Arg significantly influence cleavage rates (20-fold and 14-fold reduction, respectively).
- Mutations at P2 and P3' positions reduced cleavage by 200-400 times, highlighting their importance.
Conclusions:
- Thrombin's maximal cleavage efficiency relies heavily on P2-Pro and P3'-Arg residues.
- Natural substrates exhibit lower cleavage rates, suggesting regulation via exosite interactions.
- Residues up to 4 positions away from the cleavage site can significantly impact thrombin activity.
More Related Videos
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
06:57Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos
Published on: July 21, 2021
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...